Programming and Regulation of Metabolic Homeostasis by HDAC11

被引:79
|
作者
Sun, Lei [1 ,2 ]
de Evsikova, Caralina Marin [3 ]
Bian, Ka [1 ,2 ]
Achille, Alexandra [4 ]
Telles, Elphine [1 ]
Pei, Huadong [1 ,2 ]
Seto, Edward [1 ,2 ]
机构
[1] George Washington Univ, Canc Ctr, Washington, DC 20052 USA
[2] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA
[3] Morsani Coll Med, Dept Mol Med, Tampa, FL USA
[4] Univ S Florida, Moffitt Canc Ctr, Tampa, FL 33612 USA
来源
EBIOMEDICINE | 2018年 / 33卷
关键词
HDAC11; Obesity; Metabolic syndrome; Hepatic steatosis; UCP1; CPT1; Adiponectin; BROWN ADIPOSE-TISSUE; FATTY-ACID SYNTHESIS; DIET-INDUCED OBESITY; HISTONE DEACETYLASES; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; LIVER; EXPRESSION; MICE; INHIBITOR;
D O I
10.1016/j.ebiom.2018.06.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Histone deacetylases (HDACs) are enzymes that regulate protein functions by catalyzing the removal of acetyl and acyl groups from lysine residues. They play pivotal roles in governing cell behaviors and are indispensable in numerous biological processes. HDAC11. the last identified and sole member of class IV HDACs, was reported over a decade ago. However, its physiological function remains poorly understood. Here, we report that HDACI 1 knockout mice are resistant to high-fat diet-induced obesity and metabolic syndrome, suggesting that HDAC11 functions as a crucial metabolic regulator. Depletion of HDAC11 significantly enhanced insulin sensitivity and glucose tolerance, attenuated hypercholesterolemia, and decreased hepatosteatosis and liver damage. Mechanistically, HDAC11 deficiency boosts energy expenditure through promoting thermogenic capacity, which attributes to the elevation of uncoupling protein 1 (UCP1) expression and activity in brown adipose tissue. Moreover, loss of HDACI 1 activates the adiponectin-AdipoR-AMPK pathway in the liver, which may contribute to a reversal in hepatosteatosis. Overall, our findings distinguish HDAC11 as a novel regulator of obesity, with potentially important implications for obesity-related disease treatment. (C) 2018 The Authors. Published by Elsevier B.V.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 50 条
  • [21] Loss of HDAC11 accelerates skeletal muscle regeneration
    Nunez-Alvarez, Yaiza
    Hurtado, Erica
    Munoz, Mar
    Garcia-Tunon, Ignacio
    Rech, Gabriel E.
    Pluvinet, Raquel
    Sumoy, Lauro
    Pendas, Alberto M.
    Peinado, Miguel A.
    Suelves, Monica
    FEBS JOURNAL, 2021, 288 (04) : 1201 - 1223
  • [22] HDAC11 Is a Candidate Therapeutic Target in Multiple Myeloma
    Brayer, Jason B.
    Distler, Allison
    Meads, Mark B.
    Sahakian, Eva
    Powers, John J.
    Nguyen, Tuan
    Alsina, Melissa
    Nishihori, Taiga
    Baz, Rachid
    Pinilla-Ibarz, Javier
    Sotomayor, Eduardo Martin
    Shain, Ken H.
    BLOOD, 2017, 130
  • [23] Trapoxin A Analogue as a Selective Nanomolar Inhibitor of HDAC11
    Ho, Thanh Tu
    Peng, Changmin
    Seto, Edward
    Lin, Hening
    ACS CHEMICAL BIOLOGY, 2023, 18 (04) : 803 - 809
  • [24] Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology
    Sahakian, Eva
    Chen, Jie
    Powers, John J.
    Chen, Xianghong
    Maharaj, Kamira
    Deng, Susan L.
    Achille, Alex N.
    Lienlaf, Maritza
    Wang, Hong Wei
    Cheng, Fengdong
    Sodre, Andressa L.
    Distler, Allison
    Xing, Limin
    Perez-Villarroel, Patricio
    Wei, Sheng
    Villagra, Alejandro
    Seto, Ed
    Sotomayor, Eduardo M.
    Horna, Pedro
    Pinilla-Ibarz, Javier
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (02) : 475 - 486
  • [25] Regulation of cellular metabolism: programming and maintaining metabolic homeostasis
    Wilson, David F.
    JOURNAL OF APPLIED PHYSIOLOGY, 2013, 115 (11) : 1583 - 1588
  • [26] A Novel Hole of Histone Deacetylase 11 (HDAC11) in Regulation of Myeloid-Derived Suppressor Cell (MDSC) Expansion
    Sahakian, Eva
    Powers, John
    Rock-Klotz, Jennifer
    Adriani, Marsilio
    Woan, Karrune V.
    Merino, Oscar
    Gill, Ajaypal S.
    Deng, Susan
    Cheng, Fengdong
    Villagra, Alejandro
    Luetteke, Noreen
    Seto, Edward
    Sotomayor, Eduardo M.
    Borrello, Ivan M.
    Pinilla-Ibarz, Javier
    BLOOD, 2011, 118 (21) : 1048 - 1048
  • [27] HDAC11 as a candidate therapeutic target in multiple myeloma.
    Distler, Allison
    Brayer, Jason B.
    Meads, Mark
    Sahakian, Eva
    Powers, John Joseph
    Alsina, Melissa
    Nishihori, Taiga
    Baz, Rachid C.
    Pinilla-Ibarz, Javier
    Sotomayor, Eduardo M.
    Shain, Kenneth H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] A continuous activity assay for HDAC11 enabling re-evaluation of HDAC inhibitors
    Kutil, Z.
    Mikesova, J.
    Meleshin, M.
    Novakova, Z.
    Kozikowski, A.
    Barinka, C.
    Schutkowski, M.
    FEBS OPEN BIO, 2019, 9 : 392 - 392
  • [29] Histone deacetylase 11 (HDAC11) as a novel therapeutic target in the regulation of myeloid-derived suppressor cell (MDSC)
    Sahakian, Eva
    Powers, John
    Rock-Klotz, Jennifer
    Marsilio, Adriani
    Woan, Karune
    Merino, Oscar
    Gill, Ajaypal
    Deng, Susan
    Cheng, Fengdong
    Villagra, Alejandro
    Luekette, Noreen
    Seto, Edward
    Borrello, Ivan
    Sotomayor, Eduardo
    Pinilla, Javier I.
    CANCER RESEARCH, 2012, 72
  • [30] HDAC11: A NOVEL INFLAMMATORY BIOMARKER IN HUNTINGTON'S DISEASE
    Kumar, Vishal
    Kaur, Simranjit
    Kapil, Lakshay
    Singh, Charan
    Singh, Arti
    EXCLI JOURNAL, 2022, 21 : 647 - 650